Aclarion, Inc. (ACONW) stock
ACONWNasdaqServices-Medical LaboratoriesFiscal year ends December 31Also trades as ACON
$0.02+0.00 (0.00%)
Close on Oct 30, 2026Market cap $5.62MP/E –Yield –
Aclarion profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Aclarion's profit margin for the twelve months ending Jun 30, 2026 was -10978.5%. For fiscal 2025 it was -9551.9%, against -15293.8% the year before. The highest annual figure on record is -6513.4% in fiscal 2023.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -9551.9% | +5741.9 |
| FY2024 | Dec 31, 2024 | -15293.8% | −8780.4 |
| FY2023 | Dec 31, 2023 | -6513.4% | +5181.0 |
| FY2022 | Dec 31, 2022 | -11694.4% | −3483.9 |
| FY2021 | Dec 31, 2021 | -8210.5% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -10899.5% | −2613.6 |
| Q1 FY2026 | Mar 31, 2026 | -13498.5% | −2770.0 |
| Q4 FY2025 | Dec 31, 2025 | -10223.2% | +9221.4 |
| Q3 FY2025 | Sep 30, 2025 | -9008.0% | +474.7 |
| Q2 FY2025 | Jun 30, 2025 | -8285.9% | +2999.1 |
| Q1 FY2025 | Mar 31, 2025 | -10728.4% | +12992.2 |
| Q4 FY2024 | Dec 31, 2024 | -19444.6% | −10273.4 |
| Q3 FY2024 | Sep 30, 2024 | -9482.7% | −4247.9 |
| Q2 FY2024 | Jun 30, 2024 | -11285.0% | −2706.3 |
| Q1 FY2024 | Mar 31, 2024 | -23720.6% | −19074.1 |
| Q4 FY2023 | Dec 31, 2023 | -9171.2% | −4976.6 |
| Q3 FY2023 | Sep 30, 2023 | -5234.8% | +3727.1 |
| Q2 FY2023 | Jun 30, 2023 | -8578.7% | −111.1 |
| Q1 FY2023 | Mar 31, 2023 | -4646.5% | +22527.2 |
| Q4 FY2022 | Dec 31, 2022 | -4194.5% | −2376.3 |
| Q3 FY2022 | Sep 30, 2022 | -8961.9% | −4584.4 |
| Q4 FY2021 | Dec 31, 2021 | -8467.7% | – |
| Q3 FY2021 | Sep 30, 2021 | -27173.7% | – |
| Q2 FY2021 | Jun 30, 2021 | -1818.3% | – |
| Q1 FY2021 | Mar 31, 2021 | -4377.5% | – |